BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 31641867)

  • 21. Natural product discovery: past, present, and future.
    Katz L; Baltz RH
    J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):155-76. PubMed ID: 26739136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery.
    Ahmad G; Amiji M
    Drug Discov Today; 2018 Mar; 23(3):519-533. PubMed ID: 29326075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular and biotechnological aspects of secondary metabolites in actinobacteria.
    Salwan R; Sharma V
    Microbiol Res; 2020 Jan; 231():126374. PubMed ID: 31756597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New strategies and approaches for engineering biosynthetic gene clusters of microbial natural products.
    Li L; Jiang W; Lu Y
    Biotechnol Adv; 2017 Dec; 35(8):936-949. PubMed ID: 28323062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome editing approaches: manipulating of lovastatin and taxol synthesis of filamentous fungi by CRISPR/Cas9 system.
    El-Sayed ASA; Abdel-Ghany SE; Ali GS
    Appl Microbiol Biotechnol; 2017 May; 101(10):3953-3976. PubMed ID: 28389711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiplex conditional mutagenesis in zebrafish using the CRISPR/Cas system.
    Yin L; Maddison LA; Chen W
    Methods Cell Biol; 2016; 135():3-17. PubMed ID: 27443918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome editing in Drosophila melanogaster: from basic genome engineering to the multipurpose CRISPR-Cas9 system.
    Ren X; Holsteens K; Li H; Sun J; Zhang Y; Liu LP; Liu Q; Ni JQ
    Sci China Life Sci; 2017 May; 60(5):476-489. PubMed ID: 28527116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R; Wei P; Yang J
    Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Harnessing the native type I-B CRISPR-Cas for genome editing in a polyploid archaeon.
    Cheng F; Gong L; Zhao D; Yang H; Zhou J; Li M; Xiang H
    J Genet Genomics; 2017 Nov; 44(11):541-548. PubMed ID: 29169919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted Base Editing Systems Are Available for Plants.
    Marzec M; Hensel G
    Trends Plant Sci; 2018 Nov; 23(11):955-957. PubMed ID: 30224156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium glutamicum.
    Liu J; Wang Y; Lu Y; Zheng P; Sun J; Ma Y
    Microb Cell Fact; 2017 Nov; 16(1):205. PubMed ID: 29145843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel applications of mass spectrometry-based metabolomics in herbal medicines and its active ingredients: Current evidence.
    Wang XJ; Ren JL; Zhang AH; Sun H; Yan GL; Han Y; Liu L
    Mass Spectrom Rev; 2019 Aug; 38(4-5):380-402. PubMed ID: 30817039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Green (cell) factories for advanced production of plant secondary metabolites.
    Marchev AS; Yordanova ZP; Georgiev MI
    Crit Rev Biotechnol; 2020 Jun; 40(4):443-458. PubMed ID: 32178548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR-Cas10 assisted editing of virulent staphylococcal phages.
    Nayeemul Bari SM; Hatoum-Aslan A
    Methods Enzymol; 2019; 616():385-409. PubMed ID: 30691652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delivery technologies for genome editing.
    Yin H; Kauffman KJ; Anderson DG
    Nat Rev Drug Discov; 2017 Jun; 16(6):387-399. PubMed ID: 28337020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How CRISPR is transforming drug discovery.
    Scott A
    Nature; 2018 Mar; 555(7695):S10-S11. PubMed ID: 29517026
    [No Abstract]   [Full Text] [Related]  

  • 37. A New Class of Medicines through DNA Editing.
    Porteus MH
    N Engl J Med; 2019 Mar; 380(10):947-959. PubMed ID: 30855744
    [No Abstract]   [Full Text] [Related]  

  • 38. CRISPR/Cas system for yeast genome engineering: advances and applications.
    Stovicek V; Holkenbrink C; Borodina I
    FEMS Yeast Res; 2017 Aug; 17(5):. PubMed ID: 28505256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extending CRISPR-Cas9 Technology from Genome Editing to Transcriptional Engineering in the Genus Clostridium.
    Bruder MR; Pyne ME; Moo-Young M; Chung DA; Chou CP
    Appl Environ Microbiol; 2016 Oct; 82(20):6109-6119. PubMed ID: 27496775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in CRISPR Technologies for Microbial Strain Engineering.
    Alper HS; Beisel CL
    Biotechnol J; 2018 Sep; 13(9):e1800460. PubMed ID: 30175907
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.